EMIS Acquires Majority Stake in Pharmacy Software Company Rx Systems Limited

EMIS Group plcEMIS Group plc (AIM: EMIS), the UK's leading supplier of healthcare software to GPs, today announces that it has acquired 78.9% of the issued share capital of Rx Systems Limited ("RX"), a pharmacy software and services company, for a total consideration of up to £9.95 million.

Rx Systems has a 20.5% share of the community pharmacy market; EMIS believes that further growth in the market share can be achieved post-acquisition.

The acquisition is an important element of EMIS' continuing drive to provide 'joined-up' healthcare for NHS patients. It is anticipated that future integration of EMIS and Rx Systems technologies will enable further streamlining of electronic prescription services, benefiting patients, GPs and the 2,500 community pharmacies using Rx Systems' ProScript dispensary management system.

Future developments will see pharmacists benefit from the link with GP practices using EMIS Access, the award winning secure online patient portal. This already allows patients to request repeat medication via internet, mobile phone or digital TV, saving time and streamlining the prescription process considerably.

There will be further advantages from interoperability between EMIS Web, EMIS' next generation system, and ProScript. EMIS Web is currently being tested for EPS2 paired with ProScript.

Sean Riddell, EMIS CEO, said: "Rx Systems software has a strong reputation and a loyal community pharmacy customer base. Joining forces enables both EMIS and Rx Systems to identify the best way to provide GPs and pharmacists with appropriate levels of interoperability to further improve patient care and efficiencies in the prescribing environment. This means real benefits for patients, GPs and pharmacists alike."

For further information, please visit:
http://www.emis-online.com

Related news articles:

EPS2 (Release 2 of Connecting for Health's Electronic Prescription System) will provide increased functionality for pharmacists, GPs and patients including nomination of pharmacies, electronic prescription signing and electronic repeat dispensing.

About EMIS Group plc
EMIS was established in March 1987 by two GPs who identified an opportunity to develop and supply practice management software and computerise patients’ electronic health records, then kept on paper at GPs' surgeries.

The Group has since become the UK's leading supplier of software and related services to GP surgeries and now leads the market, with around 39 million patient records held on its platform.

The Group's latest product, EMIS Web, electronically connects GPs with other NHS professionals by enabling secure, shared, centrally hosted access to patients' cradle-to-grave electronic health records held at the Group’s data centres. The transformational system has the capability to interconnect with other NHS patient data systems to:

  • save time and money by eliminating paperwork and the re-inputting of data;
  • significantly reduce patient waiting times; and
  • reduce the risk of prescribing and treatment errors.

EMIS is headquartered in Leeds.

About Rx Systems
Rx Systems has grown rapidly since it began trading in 2004. Based in Hertfordshire and operating throughout the UK, Rx Systems has developed a range of integrated pharmacy and retail systems and services for the community pharmacy, including its core product, ProScript, a windows based dispensary management system. www.rxsystems.co.uk.

Most Popular Now

AI Catches One-Third of Interval Breast …

An AI algorithm for breast cancer screening has potential to enhance the performance of digital breast tomosynthesis (DBT), reducing interval cancers by up to one-third, according to a study published...

Great plan: Now We need to Get Real abou…

The government's big plan for the 10 Year Health Plan for the NHS laid out a big role for delivery. However, the Highland Marketing advisory board felt the missing implementation...

Researchers Create 'Virtual Scienti…

There may be a new artificial intelligence-driven tool to turbocharge scientific discovery: virtual labs. Modeled after a well-established Stanford School of Medicine research group, the virtual lab is complete with an...

From WebMD to AI Chatbots: How Innovatio…

A new research article published in the Journal of Participatory Medicine unveils how successive waves of digital technology innovation have empowered patients, fostering a more collaborative and responsive health care...

New AI Tool Accelerates mRNA-Based Treat…

A new artificial intelligence (AI) model can improve the process of drug and vaccine discovery by predicting how efficiently specific mRNA sequences will produce proteins, both generally and in various...

AI also Assesses Dutch Mammograms Better…

AI is detecting tumors more often and earlier in the Dutch breast cancer screening program. Those tumors can then be treated at an earlier stage. This has been demonstrated by...

RSNA AI Challenge Models can Independent…

Algorithms submitted for an AI Challenge hosted by the Radiological Society of North America (RSNA) have shown excellent performance for detecting breast cancers on mammography images, increasing screening sensitivity while...

AI could Help Emergency Rooms Predict Ad…

Artificial intelligence (AI) can help emergency department (ED) teams better anticipate which patients will need hospital admission, hours earlier than is currently possible, according to a multi-hospital study by the...

Head-to-Head Against AI, Pharmacy Studen…

Students pursuing a Doctor of Pharmacy degree routinely take - and pass - rigorous exams to prove competency in several areas. Can ChatGPT accurately answer the same questions? A new...

NHS Active 10 Walking Tracker Users are …

Users of the NHS Active 10 app, designed to encourage people to become more active, immediately increased their amount of brisk and non-brisk walking upon using the app, according to...

New AI Tool Illuminates "Dark Side…

Proteins sustain life as we know it, serving many important structural and functional roles throughout the body. But these large molecules have cast a long shadow over a smaller subclass...

Deep Learning-Based Model Enables Fast a…

Stroke is the second leading cause of death globally. Ischemic stroke, strongly linked to atherosclerotic plaques, requires accurate plaque and vessel wall segmentation and quantification for definitive diagnosis. However, conventional...